Dextrose Injection, Solution
Product Images NDC 70518-4219

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dextrose (NDC 70518-4219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Dextrose 50 25g 50ml(0.5g mL) 70518 4219 01)

This text provides information about a medication called DeXtrose 50, supplied in a 50mL unit of use syringe. The medication is manufactured by Hospira, Inc. and is intended for intravenous use. It contains 0.5g/mL of dextrose and should be stored at a temperature of 20-25°C. The medication is sterile and nonpyrogenic if the cap is in place and the package is intact. Directions for use can be found in the package insert. The text also includes information about the manufacturer and repackager.*

FDA Label Image

Remedy_label (Remedy Label)

This text is the label information for the medication DeXtrose 50, a 50mL injection solution with a concentration of 0.5g/mL. It is for intravenous use and comes in a package containing 10 prefilled syringes. The medication and fluid path are sterile and nonpyrogenic if the cap is in place and the package is intact. The label also includes storage instructions, expiration details, manufacturer information (Hospira, Inc), and a warning to keep the medication out of the reach of children. Additionally, there is a direction to see the package insert for further instructions and information.*

FDA Label Image

Chemical Structure (Dextrose 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.